Back to results
US 6,730,690 B2Granted
11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
AssigneeMerck & Co., Inc.
InventorsSteven H. Olson, James M. Balkovec, Yuping Zhu
Life of this patent
Estimating the term…
Abstract
Compounds having Formula I, including pharmaceutically acceptable salts, hydrates and solvates thereof: are selective inhibitors of the 11β-HSD1 enzyme. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dylsipidemia, hyperlipidemia, hypertension, Syndrome X, and other symptoms associated with NIDDM.
Claims42
A compound represented by Formula I:
- or a pharmaceutically acceptable salt or solvate thereof, wherein:
- A and B together represents C2-5alkanediyl such that they form a 3-6 membered ring with the carbon atom to which they are attached, said ring optionally containing 1 double bond or 1-2 heteroatoms selected from O, S and N, said 3-6 membered ring being optionally substituted with C1-4alkylene, oxo, ethylenedioxy or propylenedioxy, and being further optionally substituted with 1-4 groups selected from halo, C1-4alkyl, haloC1-4alkyl, C1-3acyl, C1-3acyloxy, C1-3alkoxy, C1-6alkylOC(O)—, C2-4alkenyl, C2-4alkynyl, C1-3alkoxyC1-3alkyl, C1-3alkoxyC1-3alkoxy, phenyl, CN, OH, D, NH2, NHRa and N(Ra)2 wherein Ra represents C1-3alkyl, OC1-3alkyl, C6-10arC1-6alkylene or phenyl optionally substituted with 1-3 halo groups;
- each R1 represents H or is independently selected from the group consisting of:
- OH, halo, C1-10alkyl, C1-6alkoxy and C6-10aryl, said C1-10alkyl, C6-10aryl and the alkyl portion of C1-6alkoxy being optionally substituted with 1-3 halo, OH, OC1-3alkyl, phenyl or naphthyl groups, said phenyl and naphthyl being optionally substituted with 1-3 substituents independently selected from halo, OCH3, OCF3, CH3, CF3 and phenyl, wherein said phenyl is optionally substituted with 1-3 halo groups,
- or two R1 groups taken together represent a fused C5-6alkyl or aryl ring, which may be optionally substituted with 1-2 OH or Ra groups, wherein Ra is as defined above;
- R2 is selected from the group consisting of (a) C1-14alkyl optionally substituted with 1-6 halo groups and 1-3 substituents selected from OH, OC1-3alkyl, and phenyl, said phenyl being optionally substituted with 1-4 groups independently selected from halo, OCH3, OCF3, CH3 and CF3, and said C1-3alkyl portion of OC1-3alkyl being optionally substituted with 1-3 halo groups;
- (b) phenyl or pyridyl optionally substituted with 1-3 halo, OH or Ra groups, with Ra as previously defined;
- (c) C2-10 alkenyl, optionally substituted with 1-3 substituents independently selected from halo, OH and OC1-3alkyl, said C1-3alkyl portion of OC1-3alkyl being optionally substituted with 1-3 halo groups;
- (d) CH2CO2H;
- (e) CH2CO2C1-6alkyl;
- (f) CH2C(O)NHRa wherein Ra is as previously defined;
- (g) NH2, NHRa and N(Ra)2 wherein Ra is as previously defined;
- R3 is selected from the group consisting of:
- C1-14alkyl, C2-10alkenyl, SC1-6alkyl, C6-10aryl, heterocyclyl and heteroaryl, said alkyl, alkenyl, aryl, heterocyclyl, heteroaryl and the alkyl portion of SC1-6alkyl being optionally substituted with (a) R;
- (b) 1-6 halo groups and (c) 1-3 groups selected from OH, NH2, NHC1-4alkyl, N(C1-4alkyl)2, C1-4alkyl, OC1-4alkyl, CN, C1-4alkylS(O)x— wherein x is 0, 1 or 2, C1-4alkylSO2NH—, H2NSO2—, C1-4alkylNHSO2— and (C1-4alkyl)2NSO2—, said C1-4alkyl and the C1-4alkyl portions of said groups being optionally substituted with phenyl and 1-3 halo groups, and
- R is selected from heterocyclyl, heteroaryl and aryl, said group being optionally substituted with 1-4 groups selected from halo, C1-4alkyl, C1-4alkylS(O)x—, with x as previously defined, C1-4 alkylSO2NH—, H2NSO2—, C1-4alkylNHSO2—, (C1-4alkyl)2NSO2—, CN, OH, OC1-4alkyl, and, said C1-4alkyl and the C1-4alkyl portions of said groups being optionally substituted with 1-5 halo and 1 group selected from OH and OC1-3alkyl.
13 more elements
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt or solvate thereof.
Dependencies are inferred from the claim text.